CD20‐Positive Infiltrates in Renal Allograft Biopsies with Acute Cellular Rejection Are Not Associated with Worse Graft Survival
Open Access
- 1 August 2007
- journal article
- Published by Elsevier in American Journal of Transplantation
- Vol. 7 (8) , 1968-1973
- https://doi.org/10.1111/j.1600-6143.2007.01885.x
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- The emerging role of rituximab in organ transplantationTransplant International, 2006
- B Cells in Health and DiseaseMayo Clinic Proceedings, 2006
- Nodular B-Cell Aggregates Associated with Treatment Refractory Renal Transplant Rejection Resolved by RituximabAmerican Journal of Transplantation, 2006
- B cells as antigen presenting cellsCellular Immunology, 2005
- Expression of Surfactant Protein-C, S100A8, S100A9, and B Cell Markers in Renal AllograftsJournal of the American Society of Nephrology, 2005
- Association of CD20+ Infiltrates with Poorer Clinical Outcomes in Acute Cellular Rejection of Renal AllograftsAmerican Journal of Transplantation, 2005
- Performance of Different Prediction Equations for Estimating Renal Function in Kidney TransplantationAmerican Journal of Transplantation, 2004
- Rituximab as Treatment for Refractory Kidney Transplant RejectionAmerican Journal of Transplantation, 2004
- Molecular Heterogeneity in Acute Renal Allograft Rejection Identified by DNA Microarray ProfilingNew England Journal of Medicine, 2003
- A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction EquationAnnals of Internal Medicine, 1999